SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001551986-18-000009
Filing Date
2018-08-14
Accepted
2018-08-14 16:16:35
Documents
48
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q innt630201810q.htm 10-Q 1030148
2 EXHIBIT 31.1 ex311q22018.htm EX-31.1 16120
3 EXHIBIT 31.2 ex312q22018.htm EX-31.2 16141
4 EXHIBIT 32.1 ex321q22018.htm EX-32.1 9247
5 EXHIBIT 32.2 ex322q22018.htm EX-32.2 9329
  Complete submission text file 0001551986-18-000009.txt   3526149

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT innt-20180630.xml EX-101.INS 474719
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT innt-20180630.xsd EX-101.SCH 30343
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT innt-20180630_cal.xml EX-101.CAL 43194
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT innt-20180630_def.xml EX-101.DEF 111639
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT innt-20180630_lab.xml EX-101.LAB 401202
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT innt-20180630_pre.xml EX-101.PRE 223566
Mailing Address 8480 HONEYCUTT ROAD SUITE 120 RALEIGH NC 27615
Business Address 8480 HONEYCUTT ROAD SUITE 120 RALEIGH NC 27615 919-275-1933
INNOVATE BIOPHARMACEUTICALS, INC. (Filer) CIK: 0001551986 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37797 | Film No.: 181017736
SIC: 2834 Pharmaceutical Preparations